No abstract

Coronavirus disease 2019 (COVID-19) is a contagious respiratory and vascular disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). First identified in Wuhan, China, it has caused an ongoing pandemic. Some viruses give us lifelong immunity after first infection and initially researchers thought that SARS-CoV-2 infection may give lifelong immunity after first infection but few cases of reinfection are reported both locally and internationally. We report 3 symptomatic cases of reinfection, diagnosed clinically and confirmed by positive reverse transcriptase polymerase chain reaction (RT-PCR) for SARS-CoV-2. So, everybody who survived an infection of SARS-Cov-2, should maintain universal masking and social distancing. Birdem Med J 2020; 10, COVID Supplement: 107-110

Background and objectives: Cardiovascular disease is the most common cause of death worldwide and Coronary Care Unit (CCU) plays a central role in reducing this mortality. Currently the data on mortality in CCU is very limited in our country. Our purpose of this study to provide data on mortality so that we can focus and improve the factors determining deaths in CCU. Methodology: The data of all death cases admitted inthe CCU of a tertiary level hospital between 1 January 2016 and 31 December 2017 were included for assessing the data on demography, diagnosis, and comorbidities at the time of death. Results: Among 802 cases admitted in CCU in two years, 40 patients died (5%). Male was 55% and female was 45%. Most of the death occurred in their 6 th decade of life, due to Non-ST-Elevation Myocardial Infarction (NSTEMI) and sepsis, within 24-hour of CCU admission.Common associated co-morbidities were DM (75%), hypertension (42.5%), CKD (27.5%), and hypokalemia (12.5%).Conclusions: The death rate is much lower in our CCU in comparison to global rate. The common cause of death is still NSTEMI. The common co-morbidities we found are DM, hypertension and CKD. Most of the deathsoccurred within 24-hour of admission.

Context: Non-steroidal anti-inflammatory drugs (NSAIDs) are most commonly used drugs for years for management of pain and inflammation with good efficacy. NSAIDs are increasingly used for variety of indications like rheumatoid arthritis (RA), osteoarthritis (OA), low back pain (LBP) etc. Prescribing patterns need to be evaluated periodically to increase the therapeutic efficacy, decrease adverse effects and provide feedback to prescribers. A prospective observational study was conducted among patients attending the Out Patient Department (OPD) of Orthopedic and received prescription for NSAIDs in the Mymensingh Medical College Hospital (MMCH) and Community Based Medical College Hospital (CBMCH) in Mymensingh. Material and Methods: The study was carried out on 300 (three hundreds) prescriptions for NSAIDs from orthopedic Out Patient Department (OPD) of Mymensingh Medical College Hospital (MMCH) and Community Based Medical College Hospital (CBMCH). A prospective observational study was conducted from January 2015 to December 2015. Data were collected only from the patients prescribed for NSAIDs and prescribing pattern of NSAIDs were analyzed using SPSS method version 20.1 Results: In case of orthopedic OPD patients most common NSAIDs prescribed to the patients was aceclofenac (29.33%). Others NSAIDs prescribed to the patient in pain management were ketorolac (10%), etoricoxib(8%), ibuprofen (9%), naproxen(9%), sulindac (7%) in orthopedic out patients of both Medical College Hospitals. Most of the NSAIDs were prescribed in brand name (85.34%) where only (14.76%) were prescribed in generic name in both hospitals. Conclusion: From the study it was observed that aceclofenac was the most common NSAIDS used in orthopedic OPD of CBMCH and indomethacin was the most common used NSAIDs in MMCH. Other used NSAIDs were ketorolac, naproxen, etoricoxib, ibuprofen and sulindac. J Dhaka Medical College, Vol. 27, No.2, October, 2018, Page 195-198

No abstract